Teva Branded Pharmaceutical Products competitive analysis

Explore Teva Branded Pharmaceutical Products's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jul 17, 2019An Inhalable Medicament1
May 22, 2019An Inhalable Medicament Comprising Tiotropium1
Sep 27, 2017An Inhaler Comprising A Tiotropium-Containing-Composition2
Aug 24, 2016An Inhalable Medicament Comprising Tiotropium1
Apr 22, 2015Nasal Spray Device1
Nov 12, 2014An Inhalable Pharmaceutical Composition1
Nov 5, 2014An Inhalable Medicament Comprising Tiotropium2

Latest PTAB cases involving Teva Branded Pharmaceutical Products

Discover the latest PTAB cases involving Teva Branded Pharmaceutical Products, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Teva Branded Pharmaceutical Products with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
TEVA PHARMACEUTICALS5201712
3M INNOVATIVE PROPERTIES COMPANY43141 - 14
3M UNITED KINGDOM PLC4 - - -
CHIESI FARMACEUTICI1123 - -